Novant Health backs out of North Carolina hospital buyout after FTC pressure

Novant Health is backing away from its attempt to buy two North Carolina hospitals after the Federal Trade Commission was granted an injunction in an appellate court. 

The $320 million deal would have allowed Novant to purchase Lake Norman Regional Medical Center and Davis Regional Medical Center from Community Health Systems. The FTC’s initial challenges to block the bid were unsuccessful. However, on Tuesday, the Fourth District U.S. Court of Appeals temporarily sided with the FTC in blocking the deal.

That was enough for Novant to back out, as the appeals process can take two years or more. 

Lake Norman Regional is a 123-bed facility in Morrisville, Davis Regional a 146-bed facility in Statesville. While Atrium Health is the largest provider in the state, Novant is currently the second. The FTC argued the purchase of these two regional facilities would stifle competition, especially in that region of North Carolina.

Novant Health currently operates more than 700 medical clinics and hospitals nationally and sees more than 6.7 million patients. They are headquartered in Winston-Salem. 

In its vote, the 4th circuit was split 2-1 on the case. According to coverage from the Charlotte Observer, the dissenting judge, Harvie Wilkinson, reasoned this purchase was not a merger between healthcare giants—and Davis Regional faced significant financial hardship before the attempted buyout. 

Wilkinson argued the FTC overstepped its regulatory authority.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing. 

Trimed Popup
Trimed Popup